Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- European shares subdued as surging crude sharpens focus on ECB rate path
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Abbott Labs (ABT) PT Raised to $140 at Cowen
January 27, 2021 4:24 PM ESTCowen analyst Joshua Jennings raised the price target on Abbott Labs (NYSE: ABT) to $140.00 (from $113.00) while maintaining a Outperform rating.
The analyst comments "ABT finished 2020 with 28% organic sales growth and guided to 2021 EPS growth of more than 35%, which still looks conservative. We have... More
Abbott (ABT) Tops Q1 EPS by 10c, Offers FY Guidance
January 27, 2021 7:35 AM ESTAbbott (NYSE: ABT) reported Q1 EPS of $1.45, $0.10 better than the analyst estimate of $1.35. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $9.94 billion.
GUIDANCE:
Abbott sees 2021 EPS of at least $5.00, versus the consensus of $4.37.
Abbott... More